摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-甲基-1-哌嗪基)苯硼酸 | 229009-40-9

中文名称
4-(4-甲基-1-哌嗪基)苯硼酸
中文别名
4-(4-甲基吡嗪-1-基)苯硼酸
英文名称
(4-(4-methylpiperazin-1-yl)phenyl)boronic acid
英文别名
4-(4-methyl-1-piperazinyl)phenylboronic acid;4-(4'-methylpiperazinyl)phenylboronic acid;1-[4-(4,4,5,5-tetramethyl[1–3]dioxaborolan-2-yl)phenyl]piperazine;4-(4-Methylpiperazin-1-YL)phenylboronic acid;[4-(4-methylpiperazin-1-yl)phenyl]boronic acid
4-(4-甲基-1-哌嗪基)苯硼酸化学式
CAS
229009-40-9
化学式
C11H17BN2O2
mdl
MFCD11223486
分子量
220.079
InChiKey
LSKYURVDOIDSCG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    406.2±55.0 °C(Predicted)
  • 密度:
    1.20±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.47
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.454
  • 拓扑面积:
    46.9
  • 氢给体数:
    2
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2933599090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335

SDS

SDS:5b98c799e13514555e928a2fd1e254c2
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-(4-Methylpiperazin-1-yl)phenylboronic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-(4-Methylpiperazin-1-yl)phenylboronic acid
CAS number: 229009-40-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, under −20◦C.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C11H17BN2O2
Molecular weight: 220.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(4-甲基-1-哌嗪基)苯硼酸(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichlorideN-溴代丁二酰亚胺(NBS)potassium carbonate 作用下, 以 四氢呋喃1,4-二氧六环 为溶剂, 反应 4.0h, 生成 3-bromo-5-(4-(4-methylpiperazin-1-yl)phenyl)-1H-pyrrolo[2,3-b]pyridine
    参考文献:
    名称:
    [EN] PYRROLO [2, 3-B] PYRIDINES OR PYRROLO [2, 3-B] PYRAZINES AS HPK1 INHIBITOR AND THE USE THEREOF
    [FR] PYRROLO [2, 3-B] PYRIDINES OU PYRROLO [2, 3-B] PYRAZINES COMME INHIBITEUR DE HPK1 ET LEUR UTILISATION
    摘要:
    本文披露了一种公式(AIII)或(III)的化合物,或其立体异构体,或其药用可接受的盐,以及包含该化合物的药物组合物。还披露了一种利用本文披露的化合物治疗HPK1相关疾病或疾病的方法。
    公开号:
    WO2019238067A1
  • 作为产物:
    描述:
    1-(4-溴苯基)哌嗪盐酸盐正丁基锂溶剂黄146 作用下, 以 四氢呋喃甲醇正己烷 为溶剂, 反应 2.67h, 生成 4-(4-甲基-1-哌嗪基)苯硼酸
    参考文献:
    名称:
    Inhibitors of bacterial biofilms and related methods
    摘要:
    某些多环化合物及其组合物对于减少或抑制细菌生物膜的生长以及控制细菌生物膜感染是有用的。这样的化合物和组合物在减少或抑制生物膜生长的方法以及控制涉及生物膜的细菌生物膜感染中也是有用的。
    公开号:
    US08324264B1
点击查看最新优质反应信息

文献信息

  • Structure−Activity Relationships of Monomeric C2-Aryl Pyrrolo[2,1-<i>c</i>][1,4]benzodiazepine (PBD) Antitumor Agents
    作者:Dyeison Antonow、Maciej Kaliszczak、Gyoung-Dong Kang、Marissa Coffils、Arnaud C. Tiberghien、Nectaroula Cooper、Teresa Barata、Sibylle Heidelberger、Colin H. James、Mire Zloh、Terence C. Jenkins、Anthony P. Reszka、Stephen Neidle、Sylvie M. Guichard、Duncan I. Jodrell、John A. Hartley、Philip W. Howard、David E. Thurston
    DOI:10.1021/jm901722v
    日期:2010.4.8
    comprehensive SAR investigation of the C2-position of pyrrolo[2,1-c][1,4]benzodiazepine (PBD) monomer antitumor agents is reported, establishing the molecular requirements for optimal in vitro cytotoxicity and DNA-binding affinity. Both carbocyclic and heterocyclic C2-aryl substituents have been studied ranging from single aryl rings to fused ring systems, and also styryl substituents, establishing across
    吡咯烷[2,1- c]的C2位的SAR综合研究] [1,4]苯并二氮杂(PBD)单体抗肿瘤药物的报道,建立了最佳的体外细胞毒性和DNA结合亲和力的分子要求。碳环和杂环C2-芳基取代基的研究范围从单个芳基环到稠环系统,还有苯乙烯基取代基,在80个类似物库中建立,C2-芳基和苯乙烯基取代基可显着增强DNA结合亲和力和体外细胞毒性,两者之间具有相关性。发现DNA结合亲和力和细胞毒性的最佳C2分组是C2-喹啉基部分,根据分子模型,这是由于分子在DNA小沟中的整体适合性以及与功能性分子的潜在特异性接触所致。组在凹槽的地板和墙壁中。这个类似物(在HCT-116(bowel)人肿瘤异种移植模型中显示了14l)延迟肿瘤生长。
  • Identification and SAR exploration of a novel series of Legumain inhibitors
    作者:Sharon L. Eddie、Aaron Gregson、Emma Graham、Stephanie Burton、Timothy Harrison、Roberta Burden、Christopher J. Scott、Paul B. Mullan、Rich Williams
    DOI:10.1016/j.bmcl.2019.03.019
    日期:2019.6
    This letter describes the development of a series of potent and selective small molecule Legumain inhibitors suitable as chemical probes for in vitro experiments. Our previous research had identified a dipeptide inhibitor utilizing a semi-reversible cyano warhead that generated 2, a cell active inhibitor. This work explores an alternative P2-P3 linker and further SAR exploration of the P3 group which
    这封信描述了一系列有效的和选择性的小分子Legumain抑制剂的开发,这些抑制剂适合用作体外实验的化学探针。我们之前的研究已经确定了一种利用半可逆的氰基战斗部产生的二肽抑制剂,该头可产生2种细胞活性抑制剂。这项工作探索了另一种P2-P3连接子,并进一步探索了P3基团的SAR,从而鉴定了16i,这是一种具有出色的理化特性的高效抑制剂。
  • Trifluoromethyl Benzoate: A Versatile Trifluoromethoxylation Reagent
    作者:Min Zhou、Chuanfa Ni、Yuwen Zeng、Jinbo Hu
    DOI:10.1021/jacs.8b04000
    日期:2018.6.6
    Trifluoromethyl benzoate (TFBz) is developed as a new shelf-stable trifluoromethoxylation reagent, which can be easily prepared from inexpensive starting materials using KF as the only fluorine source. The synthetic potency of TFBz is demonstrated by trifluoromethoxylation-halogenation of arynes, nucleophilic substitution of alkyl (pseudo)halides, cross-coupling with aryl stannanes, and asymmetric
    苯甲酸三氟甲酯 (TFBz) 被开发为一种新的货架稳定的三氟甲氧基化试剂,它可以很容易地从廉价的原料中制备,使用 KF 作为唯一的氟源。芳烃的三氟甲氧基化-卤化、烷基(伪)卤化物的亲核取代、与芳基锡烷的交叉偶联和烯烃的不对称双官能化证明了 TFBz 的合成效力。在冠醚络合的钾阳离子的帮助下,芳炔的前所未有的三氟甲氧基化-卤化在室温下顺利进行,这显着稳定了衍生自 TFBz 的三氟甲氧基阴离子。
  • BICYCLIC HETEROCYCLES AS FGFR INHIBITORS
    申请人:Incyte Corporation
    公开号:US20210214366A1
    公开(公告)日:2021-07-15
    The present disclosure relates to bicyclic heterocycles, and pharmaceutical compositions of the same, that are inhibitors of the FGFR enzyme and are useful in the treatment of FGFR-associated diseases such as cancer.
    本公开涉及双环杂环化合物及其药物组合物,这些化合物是FGFR酶的抑制剂,可用于治疗FGFR相关疾病,如癌症。
  • PYRAZOLOPYRIDINE COMPOUNDS AND USES THEREOF
    申请人:Incyte Corporation
    公开号:US20180072720A1
    公开(公告)日:2018-03-15
    Disclosed are compounds of Formula (I), methods of using the compounds for inhibiting HPK1 activity and pharmaceutical compositions comprising such compounds. The compounds are useful in treating, preventing or ameliorating diseases or disorders associated with HPK1 activity such as cancer.
    揭示了化合物的公式(I),使用这些化合物抑制HPK1活性的方法以及包含这些化合物的药物组合物。这些化合物在治疗、预防或改善与HPK1活性相关的疾病或紊乱方面是有用的,如癌症。
查看更多